Pneumopathies infiltrantes diffuses sous immunothérapie / Interstitial lung diseases and immunotherapy

J. Cadranel (Paris Cedex 20, France)

Source: Virtual Congress 2021 – French programme 2021
Session: French programme 2021
Session type: Language session
Number: 64

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Cadranel (Paris Cedex 20, France). Pneumopathies infiltrantes diffuses sous immunothérapie / Interstitial lung diseases and immunotherapy. Virtual Congress 2021 – French programme 2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Plethysmographic profil of patients with infiltrative lung diseases
Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases
Year: 2013


Interstitial lung disease: are we missing formes frustes of connective tissue disease?
Source: Eur Respir J 2006; 28: 893-896
Year: 2006


Place des anti-IL5 dans les pathologies éosinophiliques (hors asthme sévère) / Anti-IL-5 therapy for indications other than severe asthma
Source: Virtual Congress 2020 – French programme 2020: Part II
Year: 2020


Interstitial lung diseases
Source: HERMES Summer School 2014 - Educational material
Year: 2014

Interstitial lung diseases
Source: ERS Course 2018 - Summer school of paediatric respiratory medicine
Year: 2018

Interstitial lung diseases
Source: Eur Respir Monogr 2014; 65: 79-87
Year: 2014


Interstitial lung diseases
Source: ERS Course 2019 - Summer school of paediatric respiratory medicine 2019
Year: 2019

Interstitial lung diseases
Source: Eur Respir Monogr 2015; 70: 99-115
Year: 2015


Interstitial lung diseases
Source: Annual Congress 2012 - MS4 Interpreting high-resolution computed tomography scans: top tips
Year: 2012

Interstitial lung diseases
Source: Annual Congress 2013 –Ceremony for ERS Research Award on Idiopathic Pulmonary Fibrosis (financially supported by InterMune) followed by Clinical Year in Review I
Year: 2013


Interstitial lung diseases
Source: ERS Course 2015
Year: 2015

LATE-BREAKING ABSTRACT: Efficacy of inhaled N-acetylcystein in patients with interstitial pneumonia
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014


Mucoviscidose: enfin des traitements ciblés / Cystic fibrosis: targeted therapies, at last !
Source: Virtual Congress 2020 – French programme 2020: Part I
Year: 2020


Microbiote et cancer bronchique: l'exemple de l'immunothérapie / Microbiota and lung cancer: an example of immunotherapy
Source: Virtual Congress 2021 – French programme 2021
Year: 2021


Interstitial lung diseases today
Source: Eur Respir Mon; 2009: 46: 1–3
Year: 2009

Interstitial lung diseases in children
Source: Annual Congress 2011 - Paediatric Year in Review
Year: 2011


Interstitial lung diseases 2017
Source: International Congress 2017 – Clinical year in review
Year: 2017


Prise en charge de l’aspergillose pulmonaire chronique Chronic pulmonary aspergillosis care
Source: International Congress 2017 – French Programme 2017
Year: 2017